High Spirits: The Cannabis Business Podcast
Hosts Ben Larson and AnnaRae Grabstein serve up unfiltered insights, reveal their insiders' perspectives, and illuminate transformative ideas about the cannabis industry for people who want to make sense of it all.
High Spirits: The Cannabis Business Podcast
TWICL(Nov 16, 2026) - Market, Mavericks, Mayhem
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Market mayhem, heavy-hitting M&A, and... Nvidia? This week’s news cycle proves that the cannabis industry doesn't operate in a vacuum.
Join AnnaRae Grabstein as she teams up with the Cultivated crew (Jay Rosenthal & Jeremy Burke) and Cannabis Musings (Marc Hauser) for another unfiltered episode of This Week in Cannabis Live.
What You’ll Learn:
- The Lame Duck Distraction: How the sudden leadership shakeup at Nvidia and shifting political focus in Washington might push crucial hemp and cannabis banking policy further down the priority list.
- The Uplisting Reality Check: A frank discussion on Glasshouse's 90% slide since its NYSE debut, what it signals about institutional capital, and why DEA roadblocks are forcing a rethink of the public market strategy.
- Heavyweights & M&A: Why Organigram (backed by BAT's deep pockets) is confidently brushing off Curaleaf's counter-offer for Aurora, and why cash-rich players like Cronos Group are prioritizing consumer product sales over stock price hype.
- Winners & Losers: Why Massachusetts voters are the undisputed winners of the week, and why the DEA continues to pull the rug out from under the industry's progress.
- Vegas Prep: Insider details on where to find Ben, AnnaRae, and the rest of the crew for coffee, networking, and high-level strategy during MJBizCon.
You should tune in because the cannabis landscape shifts daily, and surviving it requires more than just reading the headlines—it demands sharp, forward-looking analysis on how these macro moves directly impact your bottom line. Join the live conversation to grab the strategic foresight you need to keep your business resilient, your strategy sharp, and your spirits high.
Have a question for us? Send us a text. We may answer it in the next show!
--
High Spirits is brought to you by Vertosa and Wolf Meyer.
Your hosts are Ben Larson and AnnaRae Grabstein.
Follow High Spirits on LinkedIn.
We'd love to hear your thoughts. Who would you like to see on the show? What topics would you like to have us cover?
Visit our website www.highspiritspod.com and listen to all of our past shows.
THANK YOU to our audience. Your engagement encourages us to keep bringing you these thought-provoking conversations.
Remember to always stay curious, stay informed, and most importantly, keep your spirits high.
Welcome And Weekly Headlines Setup
AnnaRae GrabsteinHey, hi spirits listeners. Every Friday morning, Ben and I team up with Jay Rosenthal and Jeremy Burke from Cultivated News and Mark Hauser from Cannabis Musings for this week in Cannabis Live. We get together to break down the top cannabis stories from coast to coast and beyond. If you want to keep up with the business and policy shifts we talk about, Ben and I highly recommend subscribing to the Cultivated Daily Newsletter. It's how we make sure nothing slips off our radar. But right now, let's get to the headlines. Without further ado, this is this week in Cannabis Live Canada.
SPEAKER_01This is this week in Cannabis Live. That is the Canadian National Anthem overlaid atop mountains on the Canadian flag. And we do this because we're going to be talking about a major Canadian deal, which certainly we've talked about before, but we have some insights on this week as well. I am Jay Rosenthal, that is Jeremy Burke. We are from Cultivated. Anna Ray Grabte from High Spirits and Mark Hauser from Cannabis Musings. Hello, everybody. Hello, hello. Good morning, Inviction. Nobody is spying on Cultivated this week. Um, we have not been infiltrated or honeypotted. I can uh assure you that Jeremy. I know of that we know. Well, I spend most of the time in the basement. Unless said spy is at a dog park in the west end of Toronto, nobody is spying on us. Um at least as far as I know it. Jeremy, I don't know, he can speak for himself.
AnnaRae GrabsteinI'd like to think that I'm interesting enough that there are spies that are quoting me. I'm not really sure, I guess.
SPEAKER_01Guess is whatever they are, it's hard to believe they would be more of a security threat than NVIDIA.
Nvidia Leadership Shock And Washington Fallout
SPEAKER_01And actually, that's where I want to start, even though it's not super cannabis related. I want to pause it and I a thought that's all kind of related. It certainly helps. Um deal with it all. But I actually have a I have a I have a thought that I want to get your reactions to because it is late breaking. The CEO of NVIDIA has stepped down. They're gonna replace him with an interim person internally. Um I think this is going to put a lot of pressure on what's happening in Washington. I think the lame duck session is gonna be a lot about NVIDIA, Jensen Huang, the Trump administration, what they knew and when, and not about can hemp be saved or delayed or are there banking regulations we can put through. Does anybody have any thoughts about that? Or maybe just talk about John. Anna Ray, you're first.
AnnaRae GrabsteinSo I don't know if I have thoughts about the lame duck session, except I can see what you're saying that it sounds like the electeds in the lame duck session are going to be very uh distracted. But I think what I am reminded, which I think we can ladder back to cannabis, is how much performance of CEOs and leadership do affect stock prices. Um I think as of this morning, the stock was down like 8% in the last 24 hours, which certainly is not as much as some of the cannabis stocks tend to swing. Um but when leadership has a problem, we see massive changes to um market values, um, even if the underlying business is the same. And Nvidia, uh Nvidia is one of those companies that is so big that I'm sure that the company does not rely on on Jensen to drive it forward. And there's plenty of other competent leaders, but we're still seeing like a massive shift in the in this in the public stock. And and that couldn't could could be uh compared to some of the stock volatility that that we might be seeing in cannabis right now.
SPEAKER_01Yes, I would just say the the stock price of cannabis stocks don't generally bring down entire economies. And this one actually, Mike Jeremy, we're gonna get to you last because we're gonna bridge and media and glasshouse in a sec. Mark, what say you?
SPEAKER_02Um Yeah, I I mean I think that's right. I mean, you know, uh my my you know, I've said this for years. Hemp and well, cannabis uh generally is like, you know, number 8,000 on the list of priorities for for the federal government, you know, for Congress. And now I think it's 8,001. Um and you know, I don't there are still no efforts. I mean, you uh Law 360 was reporting today um uh about I apologize for forgetting the name of the Congress person, but you know, recognizing that you know the best attempt here is going to be to get it into uh the continuing resolution to keep the government open. Uh and you know, they're singularly focused on something in there. You know, I mean the the uh and marijuana moment pointed out this morning um that uh the War Rocker Far is getting re-upped in this. So, you know, so it's not like it's it's completely gone, but it's but yeah, I mean, I think it just makes it just that much harder because focus continues to go elsewhere.
SPEAKER_01Yeah. Jeremy, focus continues to go elsewhere. You're nodding your head.
SPEAKER_04Well, yeah, I mean, I I I was I the only point I was gonna piggyback onto was I uh, you know, I speak to a lot of people who, you know, have been PubCo executives or have trained Pub co executives in front of the media. And I think, you know, what's going on with Jensen Wong is applicable to cannabis in one way, right? Is that, you know, in 2026, if you are an executive at a publicly traded company, you are sort of treated like a politician or even a rock star, you know, by many people. And so what you say matters, what you do matters. It matters for the global economy and it matters for your sector too. Uh and we see that in cannabis a lot. I mean, people really do pay attention to MSO and LP CEOs, you know, their their tone, what they're saying, what they're looking at. Um, and that is reflected in the stock price, especially, you know, with a retail heavy base. And so uh, you know, all that is to say, like, you know, we we've covered companies like Glasshouse and uh CuraLeaf and organogram, and and these are all sort of functions of what's going on in the C-suite, for better or worse. And I think that's really, really applicable in any emerging market, uh, you know, cannabis at a small scale, but uh, you know, chips, AI chips at a very, very large scale.
How CEO Behavior Moves Markets
SPEAKER_02Yeah. No, and I think I think you're, you know, this for ever since the, you know, US uh MSO started trading on the Canadian stock exchange, um, the or or you know, US operators, I should say, the this has been the the investor base, the retail investor base for cannabis, because it's fairly small, is very online. Um you know, it was sort of a meme stock-ish before meme stocks were a thing, in the t in the sense that it was a very highly connected, you know, deeply uh sort of online investor base. And I think a lot of the companies, you know, a lot of the CEOs have sort of glomped onto that. And so you have a lot of very online CEOs, um which you know works until it doesn't. And I you know, so it it it I think that also adds to there's a zillion reasons for the uh you know the outsized volatility of the stocks in this in this industry.
SPEAKER_01And I think the the the online nature of connectedness is one of the well and we we've seen it come to a head this week, not to bring everybody down from the Jensen Wong story, but um this was this is our newsletter today.
Glasshouse Drops After NYSE Debut
SPEAKER_01Uh Glasshouse is down here from New York Stock Exchange debut. Jeremy, I want to you you wrote this, but um I want to talk about that, but I also want to broaden it a bit to talk about what it might mean for the sector that one of the first two companies listed on the New York Stock Exchange is um not having a good couple of months or weeks or days. You pick. Yeah.
SPEAKER_04Um, yeah, you know, look, look, I there are a number of things going on here, and a lot of them are specific to Glasshouse and specific to the way, you know, the shareholder base and and you know, accusations against the CEO, which, you know, I haven't independently confirmed, so I want to be careful there. Um, but but look, Jay, to your to your point, you know, the stock is down 90% since June 30th when it first uh bifurcated its medical business from its recreational business to list on the New York Stock Exchange. You know, this was supposed to be a moment, I think, for the cannabis industry to show, like, hey, look, we're ready and mature enough for the big boards. And uh, you know, there's all this sort of latent, I think, you know, shareholder interest or institutional interest uh, you know, once we can get the stock listed. And I think, you know, uh, unfortunately, Glass has the story proved that wasn't the case. It didn't really get institutions lining up to invest in it. Um, and if it did, you know, the stock price would be a little bit more supported than it than it is right now. Um, you know, the other part of that is is there are, you know, on the um in the shareholder base, I mean, Mark Cahotis is a pretty infamous short seller, uh, and he is was was very long on Glasshouse and now appears to have lost confidence in the CEO and is very public about it to Mark's point on uh on X.com. And so, you know, we are seeing that reflected in the share price too. And and look, like even Glasshouse releasing numbers early and doing these things can't really seem to get it above and support, you know, uh the value that they're trying to create. And so I think, you know, it there's a real risk right now that the stock could become delisted if it sinks below a dollar a share for a long time. And I think it's at like $1.14 as of this morning. And so uh, yeah, I think it's it's not a great moment to show, you know, the institutional maturity of the sector. That being said, right, uh, you know, there are good people at Glasshouse. I mean, we've had Grand Farrer on the show a lot. I think, you know, uh, you know, I my hope is that the team can sort of figure this out and and get through it. But uh, you know, the early returns are definitely not good.
SPEAKER_01Anna Ray, this is really important in California.
Big Boards, Institutional Money, And Doubts
AnnaRae GrabsteinYes. And I I think that that the business is different from the stock price. And so what's what's important to California cannabis is is is the jobs and and that everyone is compliant and that the product is staying in the legal market and and all these things. Uh I I would caution us from using this as this signal to what all cannabis companies might do if they up list or to even draw lines to all of the rest of the public stocks, be them um on an American exchange or on a Canadian one. Um, Glasshouse is a substantively different company than most of the other public cannabis companies. Um it is not vertically integrated, it operates in one state. Um, it's just very, very different in terms of the structure, the what it's where it's competing, how it's competing, and um, and what its vision for for growth is all about. Um also its vision for growth has a lot to do with interstate commerce and being able to supply cannabis outside of the borders of California. And I think there's a lot of questions about if um Glasshouse's hypothesis around what the DEA Schedule III registration would actually allow them to do, if that's going to come to fruition, especially now that the DEA has gotten a little bit more active in rejecting um registrations from applicants in states that have dual use programs, which California does. So yes, this is important, but is it really that important to people outside of Glasshouse and outside of Glasshouse shareholders? I don't I don't know.
SPEAKER_01I don't I don't know the answer to that, but Mark, I guess one other question is not so much that this has leakage to other publicly traded cannabis companies, but my the the real question, I think, longer term is what this does to places like the New York Stock Exchange and Nasdaq saying yes to cannabis companies listing there. They if they weren't skittish before, and they were skittish before, this uh this doesn't bode necessarily well. Maybe I'm reading too much into it. What do you think?
SPEAKER_02Yeah, I you know, it's it's always hard to guess what the exchanges are thinking. Um and I uh you know, I think the the the the thing that hasn't panned out um which was what the hope was, um, and I will pat myself on the back, I kind of called this uh when this happened, was that the you know the industry is still not investable from an institutional perspective, right? Uh, you know, for you know, fundamentally. And that's the part that this industry still needs to convince people of. And, you know, and and I, you know, as far as I know, the other one that hasn't, you know, true leave as well, they you know, their their stock has been has has done better, but I don't, I'm not aware of them bring, you know, really, and I could be wrong, uh, but I'm not aware of them really being having brought in, you know, material institutional capital since they've uplisted. Sorry, since they've listed. Uh, you know, the same thing happened when um when companies uplisted from the CSE to the Toronto Stock Exchange. Uh, you know, it's the same, you know, which, you know, which required a lot of finagling and moving things around and costs. Um, and you know, as impressive as these structures are, uh, you know, I think I think it's gonna give companies, you know, other companies pause when trying to pursue this until the it's proven out more. But yeah, you know, I I think the the exchanges, uh, you know, particularly as the DEA is um being a lot more uh squirrely about issuing these licenses, um, we are you know, they're probably gonna be asking a few more questions like, is this really gonna work? So I don't I don't think it helps, that's for sure.
SPEAKER_04I think um, you know, I I think also to clarify the point, I think, you know, I think glass has been truly like part of it was the sentiment play, right? To show that there may be, you know, this latent institutional demand. I mean, I think don't think that really materialized. But I think, you know, Andrea, to your point, like very well taken that each cannabis company, you know, when you look at it and its balance sheet and its operations like should be held differently. I'm just not sure that, you know, the long only institutional investors that they're trying to attract are seeing that nuance yet, right? They just see, you know, cannabis listing and see it fall flat. And again, like I don't want to do the research. So, you know, I don't know how much um that permeates to, you know, whoever is, you know, making a purchasing decision for you know CPBIB in Canada or you know, the big mutual funds in Boston that like they, you know, the sector really sorely need by listing on the big board. So, you know, all this to say, like, again, that's uh not reporting, that's my opinion, right? Um, but I I do think that there is a risk there that, you know, watching the way these stocks moved all summer and the way this is playing out is sort of uh not gonna really uh uh solicit any more interest and solicit those good questions and that nuance NRA that you that you spoke to. Um the other thing I'll say on that is is you know, I listen to uh I always listen to Greenstone Industries earnings calls just because Ben Kovler uh is is uh you know, he says what's on his mind for better or worse. And you know, I one thing that stuck out to me he said, like, he's like, look, like there are no buyers, like we are not getting interesting questions, like this is not happening. Um, and you know, every other cannabis executive is kind of kind of say the opposite, and maybe, you know, I don't know who to believe, but uh, you know, Ben Kobler can be pretty honest, and that was a pretty stark comment, I thought.
Organigram Vs Curaleaf For Aurora
SPEAKER_01Um that you're good at the segues, Jared, because we had on um organogram CEO uh this week. Uh we're gonna have Auroras on in a couple weeks. Um, we also had on Canopy CEO. Uh we also had on uh Kronos Group CEO this week. There is a buyer, uh, in this case Organogram, it's actually BAT. Uh it's a it's a tobacco company. We had them on this week. Um, I'm not sure there this project took interesting turns this week, but there we did get uh James talking about uh a counter from CureLeaf. You wrote about it to our uh members uh this week. Talk a little bit about that because I it was a big week to have on CEOs on Cultivated, but it yeah, I don't know if there's any sort of long threads we could pull uh from what they were all saying, or maybe some of them.
SPEAKER_04Um I I'll try to land the plane on the transition. I don't I I don't I don't know if I can, but I I I think you know, two things. Like one is James Yamanaka is a very sober and serious CEO, and I think you know that that's uh uh as evidenced by organograms communications, and I certainly the way, you know, uh, you know, they've dealt with us throughout the reporting, right? Like every every company, you know, has its own way of dealing with supporters. Some yell and scream, and some sort of give you the information carefully and correctly. And I think, you know, this is the latter case, and uh so so we appreciate that. But no, I think Jay, to the point, like um one of the biggest takeaways out of the interview was that uh they feel that the bid will get done. They do feel that Aurora shareholders are going to accept this deal. Uh, it's about 780 per share above what Tierleaf offered at $6 per share. Um, you know, I I think two things from that is is one is sort of stressed uh famous like whether the deal would be accretive, and because that's exactly what Forrest was attacking on a per share basis. And the the short answer is no, it's not on a per share basis. But his his his theory and and his solution was that growth will take care of that over time and the proof will be in the pudding, right? That's up to Aurora shareholders to decide if they want to take, you know, organogram paper, right? And so I thought that was interesting. I think the second part that was interesting was that he does not seem concerned uh very much at all with CureLeaf coming with another offer. And uh, you know, I'm sure that there's conversations going on behind the scenes where, you know, maybe Aurora is confident in its shareholder base, uh uh that they wouldn't accept another Cure Leaf offer, or very the very simple fact that Boris Jordan on the earnings call uh you know did say that they wouldn't come up with another offer without diligence access. And you know, maybe Aurora never plans to give them that. Like I don't know. Um, but he seemed pretty confident the deal is gonna go through. He likes the deal. And I think uh, you know, to your point, Jay, about buyers, um, yeah, BAT is a big buyer. They're putting in 190 million. Uh, you know, they are the backstop that makes these sort of mega, I guess within cannabis, these sort of mega transactions work. Uh, and so, you know, we'll see. Uh, you know, I think KeLeaf has, you know, a couple more weeks to uh come up with a bid if they want. And so uh, you know, what I say now might not be true next week, but um, you know, I think they seem pretty confident that the this will close.
SPEAKER_01I'm gonna I'm gonna come to you, Mark, and you Anna Ray as well, but just to underscore what Jeremy said, uh James is certainly in his quarter zip era uh serious over uh CEO. He's he's squarely in the quarter zip era of his uh of his tenure there. So uh just wanted to make sure we all knew that. For those listening, I just showed a picture of him on Cultivated Live and he uh is literally wearing a quarter zip. So I'm uh I just like I just like talking what the kids talk, or at least were last year, the quarter zip era. Anna Ray, thoughts about uh where OGI, Aurora, Curaleaf is right now and any other impacts to the industry.
AnnaRae GrabsteinI I haven't spoken to James, um, but I will shout out Frank Colombo, who put out some really interesting analysis yesterday, just comparing the amount of cash on the balance sheet um of BAT and a bunch of other um large tobacco companies to the total market cap of the largest cannabis companies in the world. And I think um for James to express confidence makes a lot of sense when he has BAT on his on his shoulder because BAT has more cash than the entire market value of Cure Relief in general. So um they can flex as much as they want um right now. And if they want to buy Cure Leaf, they can do that too. Um, so I I think that this will play out as it's gonna play out. But if if BAT wants to win, I think that they are in a position to win. Um yeah.
Cronos Cash, Consumers, And Germany
SPEAKER_01The other thing uh we also had on the CEO of um Yes and uh another company with loads of cash is um Chronoscript. We had on Mike Gorensey this week. And one thing he said, which I thought was interesting, and maybe uh I don't know if it's a fresh perspective, but he actually puts they have like 800 plus billion dollars, you know, million dollars on the sorry not 800 million dollars on the books. A lot of cash to have. Here's what he said. I don't know if you guys caught this. Here we go.
SPEAKER_04More about who's buying our product and buying our stock.
SPEAKER_01Yeah, he said he cares more about who's buying his product than buying his stock, which is seems to be a an okay strategy for him thus far and for them. Um I believe it when he says it. I I I Mike has been a CEO of a cannabis company longer than maybe anybody. Yeah, he's a young guy, but he's been around maybe a decade.
AnnaRae GrabsteinHey, it it behooves every company to focus on their consumers, so that's a good Thing to hear from him.
SPEAKER_01Yeah, they have the number one edible brand in Canada. Um, you know, um, they have brands all over the place. We talked a lot about Germany. I recommend everybody sort of watch that interview because I think he's got a pretty interesting perspective on uh Aurora and organogram about what's going on in Germany, about other international markets, and even about the U.S. He he chimed in a bit there as well about I don't think he hinted at his strategy, but if he were to do things in the US, what it might look like in terms of operations and and brands. Yeah? I don't, I'm not, yeah, he said it. I'm not saying it.
SPEAKER_04I'm just no no, I I think, yeah, I no, I I always I always like talking to Mike. I think he's you know, like you said, he's he's a he's a survivor as a CEO of a Canadian cannabis firm, especially. And I think, you know, out of the early, you know, late 2010s days, there were certainly a lot of cowboys uh in the industry, and Mike was not one of them. He was building for the long term. Um and look, like I, you know, Jay, to your point, like they they do have $800 million uh of cash on their balance sheet. Uh, you know, the Aurora acquisition closed for I think uh, what was it, like $395 American at the current exchange rates. And so um, when you think of the scale of what they're able to do and what they're looking at, uh, you know, they they could be another another buyer for things. I think Mike was circumspect uh about that when we asked him, and we asked him that basically every quarter, and he's always circumspect, which he should be. Um, but you know, I'm I'm sure you know he's a smart guy and he's evaluating deals. And so uh I think they are certainly one to watch. And again, like I, you know, their brands do sell really, really well. Uh like they are always at the top of the charts in Canada. And so I think there's a real focus on the consumer. Um at the same time, you know, I uh the Canadian consumer market is small compared to the American market. And so what are they gonna do with all that cash on the balance sheet? I don't know. Um, but I imagine those conversations are being had.
SPEAKER_01He often talks about borderless brands too, which I quite like that you know, use Canada as a platform to test and build and then bring those brands to other places, which they have they have done.
AnnaRae GrabsteinUm I want to shift just uh on on Kronos Group. I I also I enjoyed the interview. I suggest everyone watch it. But just as we're talking about um tobacco companies, I think it is important to note that Kronos Group is backed by Ultra. Um, I think that they own somewhere like 40% of Kronos Group, and that came from a um $2.4 billion investment in 2018. So um this is another example of of a CEO that has the backing and the confidence of a large tobacco company that has a lot of cash and is able to flex to make decisions when they are ready for them.
SPEAKER_01He he is less quarter-zipped than James, though. Um I like saying Brady Kleman, very serious guy. Mike um is a serious guy, but is also um uh wears fleece. He wears fleece, wears t-shirts, is wearing a hat. We interviewed him. Last time we talked to him, not maybe three a month ago, was actually in a Amsterdam cafe, uh, one that they purchased from the company. He was working from there that day. Like he he is of the product. Um my words, not his, but he will tell you
Winners, Losers, And Vegas Meetups
SPEAKER_01the same thing. Um, we are shifting to winners and not that there's other stuff to talk about. We could talk about hemp, but we'll have a couple weeks to do that. Winners and losers, Mark. You look you look nervous that I'm coming to you first.
SPEAKER_02Yeah, no, I I I forgot that I just remember, you know, the losers here are are um are are I mean just all of us for um thinking that the DEA might actually, you know, uh uh be helpful uh in you know and and and lenient and um you know and and uh and consistent at least. You know, they I mean the the fact that that they are they basically are at this point really only registering companies that are in um uh purely medical only states and you know and but then being uh you know companies in pretty much every other state, but for inconsistent reasons, like everybody's get there's not like one blanket uh reason, it seems. Uh uh, you know, I think I think we again, you know, one once again, we all got our hopes up and the uh rug gets pulled. Um it shouldn't come as a surprise. It's sort of like, you know, we keep it's like the the the the classic uh um Simpsons where Sideshow Bob keeps stepping on the rake. Um and you know that that's that's the industry and and the government is the rake. So yeah, fair enough.
unknownI like that.
SPEAKER_04That's a great episode. It's it's uh classic, yeah. Yeah.
SPEAKER_01Well, I wish I had I wish I'd have the the gif up or the gif um of that, but maybe maybe next time we'll we'll bring it up whenever we feel like the VA aren't doing their job. Um or feels like they are doing their job.
SPEAKER_02I think it's sorry.
SPEAKER_01Go ahead. GIF, gif? I don't know. It came up in uh at Lasso too. Um Anna Ray.
AnnaRae GrabsteinUh um I'm gonna make a shameless plug. Uh the winners are those that are gonna be joining me and my friends in Vegas at the High Spirits Morning Mixer. Go to high spiritspod.com slash morning mixer. Come hang out with us in person. We're gonna have a great time. Coffee's on me.
SPEAKER_01Oh, I know that part. Great.
SPEAKER_04Uh we'll take you up on that. Yeah.
SPEAKER_01Yeah, seriously. I love coffee. Uh Jeremy, what do you what do you got?
SPEAKER_04Oh, I mean, my mine's just a non, I mean, we talked about already. Mine's a non-cannabis one. Jensen Long is my my loser of the week. Uh, you know, what are you doing, man? Like if that's how you want to live your life, maybe you should have gotten divorced five years ago. Uh, but I I digress. I mean, I do think it's it's emblematic that you know we have these massive, massive swaths of the economy concentrated in one person's decisions. And when that person exercises bad judgment in their personal life, uh, it does let lead you to question what they're doing in their professional life and whether you know the circularity of AI financing is good. You know, certainly uh, you know, my my long-term financial future is wrapped up in it, and so is many of ours. And I think uh, you know, it makes me upset when I see that type of behavior from people who are supposed to be leaders.
SPEAKER_01Well, I would I would say even further than that. Like one is his person, his family certainly he's done them wrong. Second is the finances of the company, that's really bad. But there are serious national security implications here too, which is probably the worst crime in all of this. Um, I mean, more than HR and certainly more than family is uh uh he put us all at risk, potentially. Uh and also the Trump administration seemed to know about it and didn't do anything about it or um sat on it. We're I think we're about to find out a lot more about all of these things. Uh yeah.
SPEAKER_04It could be um I I mean I I just you know, even uh Senate Republicans, like even Tim Scott is the one leading the charge to haul them in front of the Senate. And so maybe this is finally the end of uh, you know, Trump and people into Trump getting away with anything they want. I've said that before, you know, I've been wrong before.
SPEAKER_01So I also um I I I don't like the leather jacket. I just don't like it.
SPEAKER_04It's kind of cool. I I you know I do, unfortunately.
AnnaRae GrabsteinI like the leather jacket too. Yeah, I do. Yeah, I'm not gonna do that.
SPEAKER_04I also you know, I also wasn't uh I wasn't a nerd in high school, so I didn't, you know, so I didn't have to kind of yeah, so I don't know.
SPEAKER_01Uh I have uh I have a a a winner. Well, it's it's it's a whole state is a winner, and that is Massachusetts. Um they f every so this uh this was pointed out on Twitter, but this is from the Massachusetts Cannabis Control, whatever the organization is, the agency. Of the 91 towns that voted no on legalization, all of them voted no to repeal legalization, if that makes sense. So they made up a lot of ground. Cannabis is now, I don't know if it's wildly popular in Massachusetts, but repealing it is wildly not popular. Uh so this is the latest map. The orange there are six communities that voted no on cannabis legalization, but they all flipped to reject um Sam's efforts in this election. So that's quite interesting. For a while it looked like Dover was the last holdout, but it looked like Dover flipped as both got counted. So kudos to my home state, Massachusetts. They are winners. Uh, my loser is all of us, both financially, uh, because NVIDIA is taking a shit, and um and national security for the US, but also for everybody else. Um and one more plug, because Anna Ray got a plug for her stuff in Las Vegas. So we are also having breakfast before uh Wednesday, uh December 2nd. We'll be there for subscribers only. So we have to get our newsletter to get into the door. But once you are a subscriber, you can get into our breakfast. Find it on our website. You go to cultivated.news, go to the events page, you can sign up there. We'll have other stuff happening in Las Vegas as well. So we will see you, Anna Ray, and you, Mark Houser, and you, Jeremy Burke, in Las Vegas. I don't know if we'll be having a show that day, but it'll depend on everybody's schedule.
AnnaRae GrabsteinBut it would be fun to do one in I will be at your breakfast as well, and I will be letting you buy me coffee that morning. So sure, love it. That's great. Love it. Yeah.
SPEAKER_01So if I'm buying you coffee, you're buying me coffee. We're just really buying coffee for ourselves on different days.
SPEAKER_04It's it's like AI financing, it's coffee circularity.
AnnaRae GrabsteinYes, hopefully there's gonna be more people at our events than just the four of us um doing controlling each other, but we'll we'll see.
SPEAKER_02If not, then we'll have a minute uh and if if we're all plugging, um I'm not I'm not hosting a breakfast, but um one uh my employer with Khalifa is performing at MJ Biz. So if you're going to the conference, do not miss Wiz. Uh Mark, one question. Do we need tickets?
SPEAKER_01Probably.
SPEAKER_02I don't know yet, but if you'll give me one, if you do, I would love one, please. I believe it's at the conference itself.
SPEAKER_01So Mark, what is whiz? I will find out more. Mark, what is whiz like in his coffee?
AnnaRae GrabsteinYou know, pumpkin spice, maybe.
SPEAKER_02Well, you know, I well, I you know that's actually um it's it's her decline confidences.
SPEAKER_01So I you know, ah, it's part of the confidence. I will say uh this is here's a free tip to anybody um who's going to the show uh in Las Vegas and will actually be in the trade show, which kind of dwindling group. Um if you had if you had something you want to talk to everybody or hand out swag at the event, I would go to the Starbucks there because that line is also always endless. You get something everybody is standing in line that day, you are way above everybody else in
Wrap-Up And How To Support
SPEAKER_01that respect. Um, that's it for this show. We're gonna sing you out with the Canadian National Anthem as well. But Anna Ray, Mark, Jeremy, me. Uh thanks everybody. We will see you next week, which is the week before Thanksgiving. We won't be there Thanksgiving week, and then we'll see everybody in Las Vegas. But for now, have a good Friday, a good weekend, and we'll see everybody later.
AnnaRae GrabsteinWe hope you enjoyed this week in Cannabis Live. Thank you to our teams at Vertosa and Wolfmeyer and to our regular weekly producer Eric Rossetti. If you enjoyed this episode, please share, like, do all the things wherever you listen to podcasts, and please help us build our subscribers on YouTube by following our channel. Thanks for listening. And as always, folks, stay curious, stay informed, and most importantly, keep your spirits high.